31 – 40 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.
(
- Contribution to journal › Letter
-
Mark
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.
(
- Contribution to journal › Scientific review
-
Mark
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.
(
- Contribution to journal › Letter
- 2013
-
Mark
Loss of chromosomes is the primary event in near-haploid and low hypodiploid acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
(
- Contribution to journal › Article
-
Mark
Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia
(
- Contribution to journal › Letter
-
Mark
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
(
- Contribution to journal › Letter
-
Mark
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
(
- Contribution to journal › Article
-
Mark
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
(
- Contribution to journal › Article